Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The Health Risks and Benefits of Weight-Loss Drugs
Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cancer and dementia,
Popular weight loss drugs could be cheaper for some Americans: What you need to know
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as cancer, asthma, type 2 diabetes and weight loss - Ozempic, Rybelsus and Wegovy. Austedo and Austedo XR, used to treat Huntington’s disease.
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer’s, Study Shows. What It Means for the Stocks.
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The big pharma companies Novo Nordisk and Eli Lilly look to be the main benefactors of GLP-1 medications turning into a “catch-all pill,
Taking This Weight-Loss Medication Could Slash Dementia Risk, New Research Suggests
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.
Major Study Exposes New Health Risks of Weight Loss Drugs
A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable risks.
Sweeping review suggests weight-loss drugs’ effect on 175 conditions
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.
Weight-loss drugs linked to unexpected benefits and risks
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.
Study shows diabetes drugs' potential beyond weight loss
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
NOLA.com
7d
Can weight loss drugs curb alcohol addictions? New research looks at the possibility.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
6d
on MSN
Pennsylvania woman speaks out after Independence Blue Cross drops weight loss drug coverage
Independence Blue Cross, a major insurance company, is no longer covering drugs like Zepbound prescribed solely for weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Waltz resigns from House
Coast Guard chief fired
Raising prices again
'Days of Our Lives' star dies
Elise Stefanik testifies
Set to leave DOGE
Milley's portrait taken down
Former prosecutor faces trial
Agent fatally shot in VT
Released from prison
Gulf Coast winter storm
NC Rep. Joe John resigns
National championship win
Taliban frees 2 Americans
Fire at ski resort in Turkey
Israel’s top general resigns
Trailblazing cartoonist dies
Acting defense secretary
CBP One app shut down
SCOTUS grants new hearing
FDA approves nasal spray
Antisemitism lawsuits settled
Birthright citizenship suit
Can target schools, churches
Doug Collins hearing
Discuss strengthening ties
Judge blocks report release
To host '25 Grammy Awards
Djokovic beats Alcaraz
Silk Road founder pardoned
1st Japanese elected to HOF
Feedback